Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.5 SEK | +3.54% | +6.44% | +32.60% |
05-08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
04-17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.60% | 63.85M | |
+11.98% | 9.08B | |
-10.76% | 5.06B | |
+53.60% | 4.85B | |
+7.56% | 3.85B | |
+14.09% | 2.37B | |
-21.42% | 2.36B | |
+25.03% | 2.27B | |
-30.36% | 2.22B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Transcript : Orexo AB, Q2 2023 Earnings Call, Jul 18, 2023